Alzheimer's disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph.
Saved in:
| Title: | Alzheimer's disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph. |
|---|---|
| Authors: | Magno L; UCL Alzheimer's Research UK, Drug Discovery Institute, London, UK. l.magno@ucl.ac.uk., Lessard CB; Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL, USA., Martins M; Research Department of Structural and Molecular Biology, University College London, London, UK.; Present address: Instituto de Medicina Molecular - João Lobo Antunes, Faculdade de Medicina de Lisboa, Lisbon, Portugal., Lang V; UCL Alzheimer's Research UK, Drug Discovery Institute, London, UK., Cruz P; Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL, USA., Asi Y; Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK.; Queen Square Brain Bank for Neurological Disorders, Department of Movement Disorders, UCL Queen Square Institute of Neurology, University College London, London, UK., Katan M; Research Department of Structural and Molecular Biology, University College London, London, UK., Bilsland J; UCL Alzheimer's Research UK, Drug Discovery Institute, London, UK., Lashley T; Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK.; Queen Square Brain Bank for Neurological Disorders, Department of Movement Disorders, UCL Queen Square Institute of Neurology, University College London, London, UK., Chakrabarty P; Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL, USA., Golde TE; Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL, USA., Whiting PJ; UCL Alzheimer's Research UK, Drug Discovery Institute, London, UK. p.whiting@ucl.ac.uk.; Dementia Research Institute, UCL, London, UK. p.whiting@ucl.ac.uk. |
| Source: | Alzheimer's research & therapy [Alzheimers Res Ther] 2019 Feb 02; Vol. 11 (1), pp. 16. Date of Electronic Publication: 2019 Feb 02. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Electronic Cited Medium: Internet ISSN: 1758-9193 (Electronic) NLM ISO Abbreviation: Alzheimers Res Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30711010 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Alzheimer's disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Magno+L%22">Magno L</searchLink>; UCL Alzheimer's Research UK, Drug Discovery Institute, London, UK. l.magno@ucl.ac.uk.<br /><searchLink fieldCode="AU" term="%22Lessard+CB%22">Lessard CB</searchLink>; Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Martins+M%22">Martins M</searchLink>; Research Department of Structural and Molecular Biology, University College London, London, UK.; Present address: Instituto de Medicina Molecular - João Lobo Antunes, Faculdade de Medicina de Lisboa, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Lang+V%22">Lang V</searchLink>; UCL Alzheimer's Research UK, Drug Discovery Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Cruz+P%22">Cruz P</searchLink>; Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Asi+Y%22">Asi Y</searchLink>; Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK.; Queen Square Brain Bank for Neurological Disorders, Department of Movement Disorders, UCL Queen Square Institute of Neurology, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Katan+M%22">Katan M</searchLink>; Research Department of Structural and Molecular Biology, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Bilsland+J%22">Bilsland J</searchLink>; UCL Alzheimer's Research UK, Drug Discovery Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Lashley+T%22">Lashley T</searchLink>; Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK.; Queen Square Brain Bank for Neurological Disorders, Department of Movement Disorders, UCL Queen Square Institute of Neurology, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Chakrabarty+P%22">Chakrabarty P</searchLink>; Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Golde+TE%22">Golde TE</searchLink>; Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Whiting+PJ%22">Whiting PJ</searchLink>; UCL Alzheimer's Research UK, Drug Discovery Institute, London, UK. p.whiting@ucl.ac.uk.; Dementia Research Institute, UCL, London, UK. p.whiting@ucl.ac.uk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101511643%22">Alzheimer's research & therapy</searchLink> [Alzheimers Res Ther] 2019 Feb 02; Vol. 11 (1), pp. 16. <i>Date of Electronic Publication: </i>2019 Feb 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central+Ltd%22">BioMed Central Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101511643 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1758-9193 (Electronic) <i>NLM ISO Abbreviation: </i>Alzheimers Res Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30711010 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s13195-019-0469-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 16 Titles: – TitleFull: Alzheimer's disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Magno L – PersonEntity: Name: NameFull: Lessard CB – PersonEntity: Name: NameFull: Martins M – PersonEntity: Name: NameFull: Lang V – PersonEntity: Name: NameFull: Cruz P – PersonEntity: Name: NameFull: Asi Y – PersonEntity: Name: NameFull: Katan M – PersonEntity: Name: NameFull: Bilsland J – PersonEntity: Name: NameFull: Lashley T – PersonEntity: Name: NameFull: Chakrabarty P – PersonEntity: Name: NameFull: Golde TE – PersonEntity: Name: NameFull: Whiting PJ IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 02 Text: 2019 Feb 02 Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1758-9193 Numbering: – Type: volume Value: 11 – Type: issue Value: 1 Titles: – TitleFull: Alzheimer's research & therapy Type: main |
| ResultId | 1 |